Speaker illustration

Doctor Sina Fathieh

Wycombe Hospital, Buckinghamshire (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Association of Cardiovascular Imaging
European Association of Percutaneous Cardiovascular Interventions

Plasma lysozyme as surrogate biomarker for detection of coronary artery disease in patients without Standard Modifiable Cardiovascular Risk Factors (SMuRFless)

Event: ESC Congress 2025

Topic: Noninvasive Diagnostic Methods

Session: Pathophysiology of ischaemic heart disease

Thumbnail

Patients without conventional modifiable risk factors (SMuRFless) presenting with obstructive myocardial infarction face a significantly higher 30-day mortality

Event: ESC Congress 2025

Topic: Epidemiology, Prognosis, Outcome

Session: Biomarkers and assessing outcomes in coronary artery disease

Thumbnail

Examining the predictive value of plasma lysozyme for future all-cause mortality

Event: ESC Congress 2025

Topic: Biomarkers

Session: Biomarkers and molecular predictors in cardiovascular disease: from risk assessment to clinical application

Thumbnail

Predicting ECGs masquerading AS STEMI with machine learning

Event: ESC Congress 2024

Topic: ST-Elevation Myocardial Infarction (STEMI)

Session: Biomarkers and machine learning in acute coronary syndromes: pathways to precision diagnosis and stratification

Thumbnail

Reduction in acute coronary events without excess out of hospital cardiac arrest during the COVID-19 lockdown of 2020 in new South Wales, Australia

Event: ESC Congress 2023

Topic: Public Health

Session: Innovations in public health and health economics (4)

Thumbnail

Acute exposure to PM2.5 promotes arterial stiffening by down-regulating serine and trans-4-hydroxyproline dependent pathways - results from an Asutralian cohort metabolomic study

Event: ESC Congress 2023

Topic: Pathophysiology and Mechanisms

Session: Preclinical and clinical laboratory markers in chronic coronary syndromes

Thumbnail